Regional differences in healthcare costs at the end of life: an observational study using Swiss insurance claims data
- 15 July 2020
- journal article
- research article
- Published by Springer Nature in International Journal of Public Health
- Vol. 65 (6) , 969-979
Abstract
Objectives We evaluated healthcare cost differences at the end of life (EOL) between language regions in Switzerland, accounting for a comprehensive set of variables, including treatment intensity. Methods We evaluated 9716 elderly who died in 2014 and were insured at Helsana Group, with data on final cause of death provided by the Swiss Federal Statistical Office. EOL healthcare costs and utilization, ≥ 1 ICU admission and 10 life-sustaining interventions (cardiac catheterization, cardiac assistance device implantation, pulmonary artery wedge monitoring, cardiopulmonary resuscitation, gastrostomy, blood transfusion, dialysis, mechanical ventilation, intravenous antibiotics, cancer chemotherapies) reimbursed by compulsory insurance were examined. Results Taking into consideration numerous variables, relative cost differences decreased from 1.27 (95% CI 1.19–1.34) to 1.06 (CI 1.02–1.11) between the French- and German-speaking regions, and from 1.12 (CI 1.03–1.22) to 1.08 (CI 1.02–1.14) between the Italian- and German-speaking regions, but standardized costs still differed. Contrary to individual factors, density of home-care nurses, treatment intensity, and length of inpatient stay explain a substantial part of these differences. Conclusions Both supply factors and health-service provision at the EOL vary between Swiss language regions and explain a substantial proportion of cost differences.Keywords
This publication has 38 references indexed in Scilit:
- Intensity of treatment in Swiss cancer patients at the end-of-lifeCancer Management and Research, 2018
- Does long-term care subsidization reduce hospital admissions and utilization?Journal of Health Economics, 2018
- Evidence for overuse of medical services around the worldThe Lancet, 2017
- Choosing wisely at the end of life: the crucial role of medical indicationSwiss Medical Weekly, 2016
- Health Care Utilisation and Transitions between Health Care Settings in the Last 6 Months of Life in SwitzerlandPLOS ONE, 2016
- Variability of Intensive Care Admission Decisions for the Very ElderlyPLOS ONE, 2012
- The impact of advance care planning on end of life care in elderly patients: randomised controlled trialBMJ, 2010
- Validity of caregiver-reported hospital admission in a study on the quality of care received by terminally ill cancer patientsJournal of Clinical Epidemiology, 2010
- Development and Validation of Hospital “End-of-Life” Treatment Intensity MeasuresMedical Care, 2009
- Primary care physician supply and other key determinants of health care utilisation: the case of SwitzerlandBMC Health Services Research, 2008